1741-7015

BMC Medicine

Springer (Biomed Central Ltd.)

View prefix report (10.1186)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 4303 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact4303 DOIs
2

Add abstracts to 3168 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact3168 DOIs
3

Add license metadata to 299 records

License metadata tells indexers and readers how each article may be reused.

Low impact299 DOIs

DOIs for this ISSN

Showing the top 5 of 5977 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 A randomised controlled trial of dietary improvement for adu… (10.1186/s12916-017-0791-y)
Abstract ORCID License
220.43 868
2 How many people will need palliative care in 2040? Past tren… (10.1186/s12916-017-0860-2)
Abstract ORCID License
210.97 649
3 Post-stroke dementia – a comprehensive review (10.1186/s12916-017-0779-7)
Abstract ORCID License
207.92 591
4 The new field of ‘precision psychiatry’ (10.1186/s12916-017-0849-x)
Abstract ORCID License
201.36 483
5 Post-marketing withdrawal of 462 medicinal products because… (10.1186/s12916-016-0553-2)
Abstract ORCID License
200.82 475
6 Non-alcoholic fatty liver disease (10.1186/s12916-017-0806-8)
Abstract ORCID License
195.96 409
7 Are dementia with Lewy bodies and Parkinson’s disease dement… (10.1186/s12916-018-1016-8)
Abstract ORCID License
188.79 328
8 Impact of comorbidities on gout and hyperuricaemia: an updat… (10.1186/s12916-017-0890-9)
Abstract ORCID License
187.89 319
9 Towards understanding the de-adoption of low-value clinical… (10.1186/s12916-015-0488-z)
Abstract ORCID License
183.77 281
10 Comparative safety of anti-epileptic drugs during pregnancy:… (10.1186/s12916-017-0845-1)
Abstract ORCID License
182.95 274
11 Emerging concepts in liquid biopsies (10.1186/s12916-017-0840-6)
Abstract ORCID License
180.36 253
12 Peripheral brain-derived neurotrophic factor (BDNF) as a bio… (10.1186/s12916-015-0529-7)
Abstract ORCID License
179.98 250
13 Systematic meta-review of supported self-management for asth… (10.1186/s12916-017-0823-7)
Abstract ORCID License
178.52 239
14 Vaginal dysbiosis increases risk of preterm fetal membrane r… (10.1186/s12916-017-0999-x)
Abstract ORCID License
178.24 237
15 CONSORT 2010 Statement: updated guidelines for reporting par… (10.1186/1741-7015-8-18)
Abstract ORCID
177.62 3566
16 Surrogate endpoints in oncology: when are they acceptable fo… (10.1186/s12916-017-0902-9)
Abstract ORCID License
176.41 224
17 Preoperative optimization of patient expectations improves l… (10.1186/s12916-016-0767-3)
Abstract ORCID License
175.83 220
18 Cerebral Autosomal Dominant Arteriopathy with Subcortical In… (10.1186/s12916-017-0778-8)
Abstract ORCID License
175.68 219
19 Cognitive remission: a novel objective for the treatment of… (10.1186/s12916-016-0560-3)
Abstract ORCID License
174.32 210
20 Comparison of registered and published outcomes in randomize… (10.1186/s12916-015-0520-3)
Abstract ORCID License
174.17 209
21 Higher plasma levels of lysophosphatidylcholine 18:0 are rel… (10.1186/s12916-016-0552-3)
Abstract ORCID License
173.38 204
22 What is a clinical pathway? Refinement of an operational def… (10.1186/s12916-016-0580-z)
Abstract ORCID License
173.06 202
23 The role of tumour heterogeneity and clonal cooperativity in… (10.1186/s12916-017-0900-y)
Abstract ORCID License
170.91 189
24 Patterns of care and outcomes of patients with METAstatic so… (10.1186/s12916-017-0831-7)
Abstract ORCID License
169.51 181
25 Macrophage activation-like syndrome: an immunological entity… (10.1186/s12916-017-0930-5)
Abstract ORCID License
169.51 181
26 Epidemiology and outcomes of people with dementia, delirium,… (10.1186/s12916-017-0899-0)
Abstract ORCID License
169.15 179
27 Identifying older adults at risk of harm following elective… (10.1186/s12916-017-0986-2)
Abstract ORCID License
169.15 179
28 Toward the future of psychiatric diagnosis: the seven pillar… (10.1186/1741-7015-11-126)
Abstract ORCID
168.75 2370
29 Lifetime and 12-month prevalence of eating disorders amongst… (10.1186/s12916-016-0766-4)
Abstract ORCID License
167.47 170
30 Plasmodium falciparum dihydroartemisinin-piperaquine failure… (10.1186/s12916-015-0539-5)
Abstract ORCID License
165.91 162
31 The contribution of risk factors to socioeconomic inequaliti… (10.1186/s12916-017-0913-6)
Abstract ORCID License
162.10 144
32 Cross-national epidemiology of DSM-IV major depressive episo… (10.1186/1741-7015-9-90)
Abstract ORCID
160.70 1636
33 Transparent reporting of a multivariable prediction model fo… (10.1186/s12916-014-0241-z)
Abstract ORCID
160.12 1593
34 Collagen reorganization at the tumor-stromal interface facil… (10.1186/1741-7015-4-38)
Abstract ORCID
160.03 1586
35 Interpreting whole genome sequencing for investigating tuber… (10.1186/s12916-016-0566-x)
Abstract ORCID License
158.80 130
36 Can screening instruments accurately determine poor outcome… (10.1186/s12916-016-0774-4)
Abstract ORCID License
158.04 127
37 The CARE Plus study – a whole-system intervention to improve… (10.1186/s12916-016-0634-2)
Abstract ORCID License
156.74 122
38 Efficacy of melatonin for sleep disturbance following trauma… (10.1186/s12916-017-0995-1)
Abstract ORCID License
156.74 122
39 ‘”Why me, why now?” Using clinical immunology and epidemiolo… (10.1186/s12916-016-0606-6)
Abstract ORCID License
156.48 121
40 The renin–angiotensin system: a possible new target for depr… (10.1186/s12916-017-0916-3)
Abstract ORCID License
155.39 117
41 Comprehensive metabolic profiling of chronic low-grade infla… (10.1186/s12916-017-0974-6)
Abstract ORCID License
155.39 117
42 Advances in immunotherapy for melanoma (10.1186/s12916-016-0571-0)
Abstract ORCID License
155.11 116
43 Practical guide to exocrine pancreatic insufficiency – Break… (10.1186/s12916-017-0783-y)
Abstract ORCID License
155.11 116
44 Metabolic characterization of menopause: cross-sectional and… (10.1186/s12916-018-1008-8)
Abstract ORCID License
155.11 116
45 Current tobacco use is associated with higher rates of impla… (10.1186/s12916-015-0523-0)
Abstract ORCID License
154.27 113
46 So depression is an inflammatory disease, but where does the… (10.1186/1741-7015-11-200)
Abstract ORCID
153.72 1186
47 Collagen density promotes mammary tumor initiation and progr… (10.1186/1741-7015-6-11)
Abstract ORCID
153.72 1186
48 Diagnostic accuracy, incremental yield and prognostic value… (10.1186/s12916-017-0822-8)
Abstract ORCID License
153.69 111
49 Predicting dementia risk in primary care: development and va… (10.1186/s12916-016-0549-y)
Abstract ORCID License
153.10 109
50 Is there continued evidence for an association between abaca… (10.1186/s12916-016-0588-4)
Abstract ORCID License
153.10 109